Combining principles from biology, engineering, and materials science, bioprinting and biofabrication are reshaping how complex tissues and organ structures are built. Through layer-by-layer deposition of living cells, biocompatible matrices, and growth factors, researchers can now create functional constructs that closely replicate native tissue architecture. The precision of 3D bioprinting technologies enables the spatial placement of multiple cell types, allowing intricate vascular networks and heterogeneous structures to emerge. Biofabrication strategies extend beyond printing to include self-assembly and mold-based techniques, enabling broader application in regenerative medicine and disease modeling. With developments in printable bioinks, bioreactor design, and imaging-guided fabrication, the potential for producing patient-specific grafts is becoming more realistic. Bioprinting and biofabrication are also facilitating high-throughput drug testing by offering physiologically relevant tissue models, reducing reliance on animal studies. The integration of computational design and real-time monitoring systems further enhances construct fidelity, paving the way for transformative clinical interventions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy